-
Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)
Kinos, S., Hagman, H., Halonen, P. I., Soveri, L-M., O'Reilly, M., Pfeiffer, P., Frödin, J-E., Sorbye, H., Heervä, E., Liposits, G., Kallio, R., Ålgars, A., Ristamäki, R., Salminen, T., Bärlund, M., Shah, C-H., McDermott, R., Röckert, R., Flygare, P., Kwakman, J., & 4 others , 2 May 2024, In: Acta oncologica (Stockholm, Sweden). 63, p. 248-258 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Adjuvant chemotherapy in patients with clinically node-negative but pathologically node-positive rectal cancer in the Netherlands: A retrospective analysis
Kwakman, J. J. M., Bond, M. J. G., Demichelis, R. M., Koopman, M., Hompes, R., Elferink, M. A. G. & Punt, C. J. A., 1 Jan 2024, In: European Journal of Cancer. 197, 113466.Research output: Contribution to journal › Article › Academic › peer-review
-
Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal Cancer
on behalf of the PLCRC working group, Sept 2022, In: Clinical Colorectal Cancer. 21, 3, p. 229-235 7 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications